查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1785334

特種酵素市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、來源、應用、地區和競爭細分，2020-2030 年

Specialty Enzymes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Source, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 188 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球特種酵素市場價值為 62.2 億美元，預計到 2030 年將達到 89.1 億美元，預測期內的複合年成長率為 6.31%。受製藥、診斷、食品加工和生物技術領域需求不斷成長的推動，全球特種酶市場正在經歷強勁成長。這些酶包括蛋白酶、碳水化合物酶、脂肪酶和聚合酶，專為特定反應和應用而設計，具有高效率和高選擇性。與工業酵素不同，特種酵素的用量較小，但附加價值很高，尤其是在醫學診斷、治療和研究領域。在製藥業，特種酵素擴大用於藥物配方、生物催化和作為治療劑，特別是用於治療酵素缺乏症和代謝疾病。慢性病的增加、人口老化以及對個人化醫療的興趣進一步刺激了需求。在分子診斷中，聚合酶和核酸酶等酶在DNA擴增和分析中起著至關重要的作用，提高了疾病檢測的準確性和速度。

市場概覽
預測期 2026-2030
2024年市場規模 62.2億美元
2030年市場規模 89.1億美元
2025-2030 年複合年成長率 6.31%
成長最快的領域 製藥
最大的市場 北美洲

關鍵市場促進因素

對先進醫療保健解決方案的需求不斷成長

主要市場挑戰

生產成本高

主要市場趨勢

永續性與生物催化

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：全球特種酵素市場展望

  • 市場規模和預測
    • 按價值和數量
  • 市場佔有率和預測
    • 依類型（蛋白酶、聚合酶和核酸酶、碳水化合物酶、脂肪酶等）
    • 依來源（微生物、植物、動物）
    • 按應用（生物技術、製藥、診斷和研發）
    • 按地區（北美、歐洲、亞太、南美、中東和非洲）
    • 按公司分類（2024）
  • 市場地圖
    • 按類型
    • 按來源
    • 按應用
    • 按地區
  • 定價分析

第5章：歐洲特種酵素市場展望

  • 市場規模和預測
    • 按價值和數量
  • 市場佔有率和預測
    • 依類型（蛋白酶、聚合酶和核酸酶、碳水化合物酶、脂肪酶等）
    • 依來源（微生物、植物、動物）
    • 按應用（生物技術、製藥、診斷和研發）
    • 按地區
  • 定價分析
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第6章：亞太特種酵素市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 定價分析
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第7章：北美特種酵素市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 定價分析
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第8章：中東和非洲特種酵素市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 定價分析
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國

第9章：南美洲特種酵素市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 定價分析
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第10章：市場動態

  • 驅動程式
    • 消化系統疾病盛行率不斷上升
    • 在藥品製造上的高使用率
    • 各跨國酵素製造商持續投資生物技術和遺傳學
  • 挑戰
    • 高成本和維護問題
    • 監管挑戰

第 11 章：市場趨勢與發展

  • 最新動態
  • 併購
  • 產品發布

第 12 章：全球特種酵素市場：SWOT 分析

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • F. Hoffmann-La Roche AG
  • Codexis Inc.
  • BASF SE
  • Koninklijke DSM NV
  • DuPont Nutrition Biosciences
  • Advanced Enzyme Technologies Limited
  • Novozymes A/S
  • Amano enzyme Inc.
  • BBI Solutions OEM Limited
  • Sekisui Diagnostics

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 14437

Global Specialty Enzymes Market was valued at USD 6.22 billion in 2024 and is expected to reach USD 8.91 billion by 2030 with a CAGR of 6.31% during the forecast period. The global specialty enzymes market is experiencing strong growth, driven by rising demand across pharmaceuticals, diagnostics, food processing, and biotechnology sectors. These enzymes, which include proteases, carbohydrases, lipases, and polymerases, are designed for specific reactions and applications, offering high efficiency and selectivity. Unlike industrial enzymes, specialty enzymes are used in smaller volumes but add high value, particularly in medical diagnostics, therapeutics, and research. In the pharmaceutical industry, specialty enzymes are increasingly used in drug formulation, biocatalysis, and as therapeutic agents, especially for treating enzyme deficiency disorders and metabolic conditions. The rise in chronic diseases, aging populations, and interest in personalized medicine are further fueling demand. In molecular diagnostics, enzymes such as polymerases and nucleases play a crucial role in DNA amplification and analysis, enhancing the accuracy and speed of disease detection.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.22 Billion
Market Size 2030USD 8.91 Billion
CAGR 2025-20306.31%
Fastest Growing SegmentPharmaceuticals
Largest MarketNorth America

Key Market Drivers

Growing demand for advanced healthcare solutions

The growing demand for advanced healthcare solutions is significantly impacting the specialty enzymes market. As healthcare systems around the world shift towards precision medicine, targeted therapies, and early diagnostics, specialty enzymes have emerged as essential components in these innovations. These enzymes are tailored for specific biological reactions, making them ideal for complex medical applications such as drug formulation, gene therapy, and diagnostic testing. In drug development, specialty enzymes are used to synthesize active pharmaceutical ingredients with high specificity and fewer side effects. They also support biocatalysis processes that enhance the efficiency and environmental sustainability of pharmaceutical manufacturing. Enzyme replacement therapies, which treat rare genetic and metabolic disorders, are gaining traction as awareness and diagnosis improve. This has created a surge in demand for enzymes that can be used directly as therapeutic agents. In diagnostics, specialty enzymes enable accurate and rapid detection of diseases through applications such as polymerase chain reactions (PCR), ELISA tests, and next-generation sequencing. These tools have become increasingly important in identifying conditions ranging from infectious diseases to cancer and genetic disorders.

With aging populations and a rise in lifestyle-related illnesses, there is increased pressure on healthcare systems to adopt technologies that are both effective and scalable. Specialty enzymes support this need by improving treatment outcomes and enabling high-throughput diagnostic platforms. Biotechnology and pharmaceutical companies are investing in enzyme engineering to develop more stable and efficient products. As healthcare moves toward more personalized, data-driven models, the role of specialty enzymes in diagnostics and therapeutics will continue to expand significantly.

Key Market Challenges

High production cost

High production cost is a significant barrier in the specialty enzymes market. These enzymes are typically produced through advanced biotechnological methods such as microbial fermentation, recombinant DNA technology, and protein engineering. Each stage of development-from strain selection and genetic modification to purification and formulation-requires specialized equipment, skilled labor, and stringent quality control, all of which contribute to elevated manufacturing costs. The complexity of maintaining enzyme activity and stability throughout the production process further adds to expenses. Specialty enzymes often need to retain functionality under specific pH, temperature, or moisture conditions, which calls for customized formulations and storage solutions. These requirements make large-scale production more expensive compared to standard industrial enzymes. For pharmaceutical and diagnostic applications, the cost increases due to the need for clinical validation, regulatory compliance, and purity standards. High-purity enzymes must be free from contaminants and consistent in performance, leading to costly purification and testing procedures. This financial burden can limit the adoption of specialty enzymes, especially in emerging markets or in price-sensitive sectors such as food processing. The high cost of production also impacts pricing strategies, reducing profit margins and making it harder for smaller companies to compete. Reducing production costs through innovation and process optimization is key to expanding market access.

Key Market Trends

Sustainability & Biocatalysis

Sustainability and biocatalysis are becoming central drivers in the specialty enzymes market, as industries seek cleaner, greener alternatives to traditional chemical processes. Enzymes act as biocatalysts, enabling environmentally friendly reactions with high specificity and lower energy requirements. This aligns with global efforts to reduce carbon footprints and minimize hazardous waste across sectors like pharmaceuticals, textiles, food processing, and biofuels. In chemical manufacturing, enzymes replace harsh solvents and high-temperature reactions, supporting eco-friendly production while improving process efficiency. This shift is particularly important in regulated industries under increasing pressure to meet sustainability benchmarks and environmental standards. Biocatalysis also offers benefits such as reduced water consumption and fewer byproducts, which help companies optimize resource usage and reduce costs. In biofuel production, enzymes play a vital role in breaking down biomass into fermentable sugars, supporting the transition to renewable energy sources. Governments and private investors are backing such enzyme-based innovations to achieve climate targets and foster circular economy practices. Consumer demand for sustainable products is also influencing manufacturers to integrate biocatalysts into their workflows.The push for green chemistry is expected to accelerate investment in enzyme discovery, engineering, and industrial-scale application. Biocatalysis is not just a technological advancement-it is a strategic necessity for companies aiming to lead in a sustainable future.

Key Market Players

  • F. Hoffmann-La Roche AG
  • Codexis Inc.
  • BASF SE
  • Koninklijke DSM N.V.
  • DuPont Nutrition Biosciences
  • Advanced Enzyme Technologies Limited
  • Novozymes A/S
  • Amano enzyme Inc.
  • BBI Solutions OEM Limited
  • Sekisui Diagnostics

Report Scope:

In this report, the Global Specialty Enzymes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Specialty Enzymes Market, By Type:

  • Proteases
  • Polymerases & Nucleases
  • Carbohydrases
  • Lipases
  • Others

Specialty Enzymes Market, By Source:

  • Microorganisms
  • Plants
  • Animals

Specialty Enzymes Market, By Application:

  • Biotechnology
  • Pharmaceuticals
  • Diagnostics
  • Research & Development

Specialty Enzymes Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Specialty Enzymes Market.

Available Customizations:

Global Specialty Enzymes Market report with the given Market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Specialty Enzymes Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value & Volume
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
    • 4.2.2. By Source (Microorganisms, Plants, Animals)
    • 4.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
    • 4.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 4.2.5. By Company (2024)
  • 4.3. Market Map
    • 4.3.1. By Type
    • 4.3.2. By Source
    • 4.3.3. By Application
    • 4.3.4. By Region
  • 4.4. Pricing Analysis

5. Europe Specialty Enzymes Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
    • 5.2.2. By Source (Microorganisms, Plants, Animals)
    • 5.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
    • 5.2.4. By Region
  • 5.3. Pricing Analysis
  • 5.4. Europe: Country Analysis
    • 5.4.1. France Specialty Enzymes Market Outlook
      • 5.4.1.1. Market Size & Forecast
        • 5.4.1.1.1. By Value & Volume
      • 5.4.1.2. Market Share & Forecast
        • 5.4.1.2.1. By Type
        • 5.4.1.2.2. By Source
        • 5.4.1.2.3. By Application
    • 5.4.2. Germany Specialty Enzymes Market Outlook
      • 5.4.2.1. Market Size & Forecast
        • 5.4.2.1.1. By Value & Volume
      • 5.4.2.2. Market Share & Forecast
        • 5.4.2.2.1. By Type
        • 5.4.2.2.2. By Source
        • 5.4.2.2.3. By Application
    • 5.4.3.United Kingdom Specialty Enzymes Market Outlook
      • 5.4.3.1. Market Size & Forecast
        • 5.4.3.1.1. By Value & Volume
      • 5.4.3.2. Market Share & Forecast
        • 5.4.3.2.1. By Type
        • 5.4.3.2.2. By Source
        • 5.4.3.2.3. By Application
    • 5.4.4. Italy Specialty Enzymes Market Outlook
      • 5.4.4.1. Market Size & Forecast
        • 5.4.4.1.1. By Value & Volume
      • 5.4.4.2. Market Share & Forecast
        • 5.4.4.2.1. By Type
        • 5.4.4.2.2. By Source
        • 5.4.4.2.3. By Application
    • 5.4.5. Spain Specialty Enzymes Market Outlook
      • 5.4.5.1. Market Size & Forecast
        • 5.4.5.1.1. By Value & Volume
      • 5.4.5.2. Market Share & Forecast
        • 5.4.5.2.1. By Type
        • 5.4.5.2.2. By Source
        • 5.4.5.2.3. By Application

6. Asia-Pacific Specialty Enzymes Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
    • 6.2.2. By Source (Microorganisms, Plants, Animals)
    • 6.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
    • 6.2.4. By Region
  • 6.3. Pricing Analysis
  • 6.4. Asia-Pacific: Country Analysis
    • 6.4.1. China Specialty Enzymes Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value & Volume
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Type
        • 6.4.1.2.2. By Source
        • 6.4.1.2.3. By Application
    • 6.4.2. India Specialty Enzymes Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value & Volume
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Type
        • 6.4.2.2.2. By Source
        • 6.4.2.2.3. By Application
    • 6.4.3. Japan Specialty Enzymes Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value & Volume
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Type
        • 6.4.3.2.2. By Source
        • 6.4.3.2.3. By Application
    • 6.4.4. South Korea Specialty Enzymes Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value & Volume
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Type
        • 6.4.4.2.2. By Source
        • 6.4.4.2.3. By Application
    • 6.4.5. Australia Specialty Enzymes Market Outlook
      • 6.4.5.1. Market Size & Forecast
        • 6.4.5.1.1. By Value & Volume
      • 6.4.5.2. Market Share & Forecast
        • 6.4.5.2.1. By Type
        • 6.4.5.2.2. By Source
        • 6.4.5.2.3. By Application
        • 6.4.5.2.4. By Application

7. North America Specialty Enzymes Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
    • 7.2.2. By Source (Microorganisms, Plants, Animals)
    • 7.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
    • 7.2.4. By Region
  • 7.3. Pricing Analysis
  • 7.4. North America: Country Analysis
    • 7.4.1. United States Specialty Enzymes Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value & Volume
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Type
        • 7.4.1.2.2. By Source
        • 7.4.1.2.3. By Application
    • 7.4.2. Canada Specialty Enzymes Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value & Volume
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Type
        • 7.4.2.2.2. By Source
        • 7.4.2.2.3. By Application
    • 7.4.3. Mexico Specialty Enzymes Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value & Volume
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Type
        • 7.4.3.2.2. By Source
        • 7.4.3.2.3. By Application

8. Middle East and Africa Specialty Enzymes Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
    • 8.2.2. By Source (Microorganisms, Plants, Animals)
    • 8.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
    • 8.2.4. By Region
  • 8.3. Pricing Analysis
  • 8.4. MEA: Country Analysis
    • 8.4.1. Saudi Arabia Specialty Enzymes Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value & Volume
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Type
        • 8.4.1.2.2. By Source
        • 8.4.1.2.3. By Application
    • 8.4.2. South Africa Specialty Enzymes Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value & Volume
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Type
        • 8.4.2.2.2. By Source
        • 8.4.2.2.3. By Application
    • 8.4.3. UAE Specialty Enzymes Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value & Volume
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Type
        • 8.4.3.2.2. By Source
        • 8.4.3.2.3. By Application

9. South America Specialty Enzymes Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
    • 9.2.2. By Source (Microorganisms, Plants, Animals)
    • 9.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
    • 9.2.4. By Region
  • 9.3. Pricing Analysis
  • 9.4. South America: Country Analysis
    • 9.4.1. Brazil Specialty Enzymes Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value & Volume
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Type
        • 9.4.1.2.2. By Source
        • 9.4.1.2.3. By Application
    • 9.4.2. Colombia Specialty Enzymes Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value & Volume
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Type
        • 9.4.2.2.2. By Source
        • 9.4.2.2.3. By Application
    • 9.4.3. Argentina Specialty Enzymes Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value & Volume
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Type
        • 9.4.3.2.2. By Source
        • 9.4.3.2.3. By Application

10. Market Dynamics

  • 10.1. Drivers
    • 10.1.1. Increasing Prevalence of Digestive Disorders
    • 10.1.2. High Usage in Drugs Manufacturing
    • 10.1.3. Continued Investment in Biotechnology and Genetics by Various Multinational Enzyme Manufacturers
  • 10.2. Challenges
    • 10.2.1. High cost and Maintenance Issues
    • 10.2.2. Regulatory challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Mergers & Acquisitions
  • 11.3. Product Launches

12. Global Specialty Enzymes Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. F. Hoffmann-La Roche AG
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. SWOT Analysis
  • 14.2. Codexis Inc.
  • 14.3. BASF SE
  • 14.4. Koninklijke DSM N.V.
  • 14.5. DuPont Nutrition Biosciences
  • 14.6. Advanced Enzyme Technologies Limited
  • 14.7. Novozymes A/S
  • 14.8. Amano enzyme Inc.
  • 14.9. BBI Solutions OEM Limited
  • 14.10. Sekisui Diagnostics

15. Strategic Recommendations

16. About Us & Disclaimer